Business Description
Anixa Biosciences Inc
NAICS : 541713
SIC : 2834
ISIN : US45069V2034
Description
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 87.53 | |||||
| Equity-to-Asset | 0.95 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 7.3 | |||||
| 3-Year EPS without NRI Growth Rate | 10.3 | |||||
| 3-Year FCF Growth Rate | 10.5 | |||||
| 3-Year Book Growth Rate | 29.3 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 13.76 | |||||
| 9-Day RSI | 19.43 | |||||
| 14-Day RSI | 25.02 | |||||
| 6-1 Month Momentum % | 25.11 | |||||
| 12-1 Month Momentum % | -33.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.31 | |||||
| Quick Ratio | 11.31 | |||||
| Cash Ratio | 10.35 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.7 | |||||
| Shareholder Yield % | -4.09 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -3989.05 | |||||
| ROE % | -51.57 | |||||
| ROA % | -49.55 | |||||
| ROIC % | -6163.07 | |||||
| 3-Year ROIIC % | -1324.36 | |||||
| ROC (Joel Greenblatt) % | -7830.48 | |||||
| ROCE % | -59.39 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 321.43 | |||||
| PB Ratio | 3.32 | |||||
| Price-to-Tangible-Book | 3.31 | |||||
| EV-to-EBIT | -3.7 | |||||
| EV-to-Forward-EBIT | -5.56 | |||||
| EV-to-EBITDA | -3.71 | |||||
| EV-to-Revenue | 241.98 | |||||
| EV-to-Forward-Revenue | 343.02 | |||||
| EV-to-FCF | -6.07 | |||||
| Price-to-Net-Current-Asset-Value | 3.36 | |||||
| Price-to-Net-Cash | 3.69 | |||||
| Earnings Yield (Greenblatt) % | -27.03 | |||||
| FCF Yield % | -11.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ANIX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Anixa Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.21 | ||
| EPS (TTM) ($) | -0.39 | ||
| Beta | 0.2 | ||
| Volatility % | 73.08 | ||
| 14-Day RSI | 25.02 | ||
| 14-Day ATR ($) | 0.173061 | ||
| 20-Day SMA ($) | 2.563 | ||
| 12-1 Month Momentum % | -33.63 | ||
| 52-Week Range ($) | 2.145 - 5.13 | ||
| Shares Outstanding (Mil) | 32.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Anixa Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Anixa Biosciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Anixa Biosciences Inc Frequently Asked Questions
What is Anixa Biosciences Inc(ANIX)'s stock price today?
The current price of ANIX is $2.25. The 52 week high of ANIX is $5.13 and 52 week low is $2.15.
When is next earnings date of Anixa Biosciences Inc(ANIX)?
The next earnings date of Anixa Biosciences Inc(ANIX) is 2025-03-12 Est..
Does Anixa Biosciences Inc(ANIX) pay dividends? If so, how much?
Anixa Biosciences Inc(ANIX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers